Swedish oncology firm Elekta of Stockholm achieved a 9% gain in net sales for the first nine months of fiscal year 2010.
For the nine-month period (end-January 31), net sales rose to 4.83 billion kronor ($676 million U.S.), compared with 4.15 billion kronor ($581 million) in the same period of 2009.
Operating profit increased to 553 million kronor ($77.4 million) in the first nine months of the fiscal year, compared with 309 million kronor ($43.3 million) in the same period a year ago.
The Stockholm-based company's outlook for this fiscal year remains the same, with projected net sales growth of more than 8% and an expected operating profit gain of approximately 35%.
Related Reading
Elekta wins Calif. VMAT contract, February 18, 2010
Elekta reaches VMAT milestone, February 12, 2010
UVA buys Elekta's Leksell, December 21, 2009
Elekta posts 2010 six-month results, December 10, 2009
Elekta nets Russian contract, November 4, 2009
Copyright © 2010 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
